ISRCTN ISRCTN13666367
DOI https://doi.org/10.1186/ISRCTN13666367
Submission date
11/09/2019
Registration date
24/09/2019
Last edited
11/10/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Depression is a mental health condition where a person feels constantly very sad and low in mood for two weeks or more. It affects people in different ways. Sufferers can feel hopeless, anxious and lose interest in doing things they used to enjoy. It can also lead to problems with sleeping, feeling constantly tired, a loss of appetite and a low sex drive. In the most extreme cases, it can result in a person harming themselves or attempting to take their own life (suicide). The study aims to compare two treatment methods for depression, cognitive control training and behavioural activation

Who can participate?
Patients aged 18 – 50 with major depressive disorder

What does the study involve?
Participants are randomly allocated into Cognitive Control Training (CCT) or the active control group (Behavioral Activation). They are assessed with questionnaires a before and after the 18-session intervention (twice weekly).

What are the possible benefits and risks of participating?
Possible benefits of participating in this study include improvement in their condition and relief from symptoms. Improvement in cognitive and mood symptoms is likely. The intervention will target mood regulation and long-term sustainable strategies to deal with depression. The study doctor/researcher will be monitoring participants' condition more closely than usual. The findings of this study will be helpful in developing new strategies for patients with depression. There are no costs to participants and they will not be paid for their participation. The tests, examination and treatment will be free of cost. There are no risks involved in the treatment, but since the treatment requires participants to not change the dose of medication a month before and 3 months after the intervention there could be worsening of symptoms, in such a case they will be independently assessed by a psychiatrist and will be removed from the study.

Where is the study run from?
1. NIMHANS OPD
2. NIMHANS Centre for Well Being (NCWB)

When is the study starting and how long is it expected to run for?
October 2017 to October 2019

Who is funding the study?
National Institute of Mental Health and Neuroscience (India)

Who is the main contact?
Meenakshi Banerjee
meenakshi.banerjee@gmail.com

Contact information

Ms Meenakshi Banerjee
Public

225 Cauvery Hostel
NIMHANS
Hosur Road
Bangalore
560029
India

ORCiD logoORCID ID 0000-0001-9883-9004
Phone +91 (0)8197292827
Email meenakshi.banerjee@gmail.com

Study information

Study designRandomised controlled trial with single-blind pre-post and follow up design
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleCognitive control training for depression: a randomised controlled trial
Study acronymCCT-D
Study objectivesHypothesis 1: There will be no difference in measures of depression, anxiety, emotion regulation, metacognition, neuro-cognitions and quality of life, before and after cognitive control training
Hypothesis 2: There will be no difference in measures of depression, anxiety, emotion regulation, metacognition, neuro-cognitions and quality of life, between patients who recieve cognitive control training and behavioural activation
Ethics approval(s)Approved 18/07/2016, NIMHANS (Human) Ethics Committee (National Institute for Mental Health and Neuroscience (NIMHANS), Hosur Road, Hombegowda Nagar, Bangalore, India; +91 (0) 8026995000; ms@nimhans.ac.in), ref: NIMH/DO/ETHICS SUB-COMMITTEE29thMEETING/2016
Health condition(s) or problem(s) studiedMajor depressive disorder
InterventionAllocation to groups was done with a computer-generated random number table.

Arm 1 (Intervention) Cognitive Control Training:
18 sessions (twp per week) training executive control processes - working memory, response inhibition and mental flexibility keeping an affective framework to suit patients with depression and decrease rumination and improve metacognition.

Arm 2 (Control) Behavioural Activation:
18 sessions (two per week) behaviour activation adapted from Jacobson (2001) and suggestions by Veale et al (2007).

Post-intervention CGI (Clinical Global Index) was done by an expert blind rater.
Intervention typeBehavioural
Primary outcome measureDepression measured using Beck's Depression Inventory (BDI) at baseline and 9 weeks
Secondary outcome measures1. Illness severity measured using the Clinical Global Index (CGI) at baseline and 9 weeks
2. Neuro-cognitive measures at baseline and 9 weeks:
2.1. Spatial Span
2.2. Digit Span (WMS III)
Overall study start date01/10/2017
Completion date15/10/2019

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit50 Years
SexBoth
Target number of participants60
Total final enrolment60
Key inclusion criteria1. Major Depressive Disorder (as primary diagnosis)
2. Score of 17 or above on Beck’s Depression Inventory (BDI)
3. Age range of 18-50 years
4. Comprehension of written and spoken English/Hindi
5. Right handedness
6. Normal or corrected vision or hearing
7. Stable on medication dosage for one month
Key exclusion criteria1. History suggestive of neurological, neurosurgical conditions and /or history of head injury And/or mental retardation on clinical assessment
2. Diagnosis of schizophrenia, Bipolar Affective Disorder, Severe Depression with psychotic symptoms, Delusional disorder, current psychoactive substance abuse and/or dependence (except nicotine)
3. Any structured psychological intervention in the past 6 months
4. Any neurocognitive intervention and/or neuropsychological assessments
5. Have received ECT (in last 6 months)
Date of first enrolment01/10/2017
Date of final enrolment10/09/2019

Locations

Countries of recruitment

  • India
  • United Kingdom

Study participating centres

National Institute of Mental Health and Neuroscience (NIMHANS)
Hosur Road
Hombegowda Nagar
Bangalore
Karnataka
560029
India
National Institute of Mental Health and Neurosciences Centre for Well-Being
9th Main Road
Stage, BTM Layout 1
Bengaluru
Karnataka
560076
United Kingdom

Sponsor information

National Institute for Mental Health and Neuroscience (NIMHANS)
Government

Hosur Road
Hombegowda Nagar
Bangalore
560029
India

Phone +91 (0)8026995000
Email ms@nimhans.ac.in
Website http://www.nimhans.ac.in
ROR logo "ROR" https://ror.org/0405n5e57

Funders

Funder type

Government

National Institute of Mental Health and Neuroscience

No information available

Results and Publications

Intention to publish date30/12/2019
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planPublication 1: Letter to author/correspondence regarding usefulness of affective material for Cognitive Control Training for Depression
Publication 2: Literature review of CCT in Depression
Publication 3: Methodology
Publication 4: Final paper with results of the trial
IPD sharing planThe datasets generated and/or analysed during the current study during this study will be included in the subsequent results publication.

Editorial Notes

11/10/2019: Total final enrolment number added.
19/09/2019: Trial's existence confirmed by ethics committee.